Degu Dare

Senior Epidemiologist

Degu Dare is a medical doctor with 24 years professional experience working in TB and HIV disease control programmes and epidemiology.

Degu has contributed to over 60 academic articles and is an expert in TB epidemiology, infectious disease management (including TB and HIV/AIDS), capacity building, ministry of health processes, community-based TB services, integrated diabetes/TB/HIV service delivery, TB surveillance and contact screening and health systems strengthening. Degu has previously worked at the World Health Organization, Johns Hopkins University, and Management Sciences for Health.

As the project director of the USAID-funded Challenge TB Project in Ethiopia, Degu developed innovative TB contact screening approaches, led a nation-wide survey on population-based TB awareness and stigma, coordinated the introduction of an integrated specimen transport system both for sputum and viral load testing and introduced innovative digital technologies (99DOTS, online screening, video-conferencing, DHIS-2) to support capacity building, case finding and adherence support.

In addition to his Doctorate in International Public Health from the University of Bergen, Norway in 2007, Degu holds a Master of Business Administration from Ashland University, USA. Degu currently serves as Associate Editor for two peer-reviewed journals: Public Health Action and Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, and is the current Vice Chair of the Union’s HIV Section. Degu was also part of the WHO-convened global team that developed global TB data compendium for the patient pathway analysis compendium.

Within KNCV, Degu supports the development and revision of national strategic plans for TB, epidemiological reviews and assessments, and the design and implementation of innovative health projects, including community-based TPT, childhood TB diagnosis, and digital health interventions. Degu also works on the implementation of the KNCV-led patient-centered framework for strategic planning in Africa and led the research and epidemiology team contributing to design of KNCV’s innovation pathways and KNCV’s research ethics review. Degu represents KNCV on the Global Fund’s TB measurement taskforce.

Tuberculose is een infectieziekte die wordt veroorzaakt door een bacterie, de Mycobacterium tuberculosis.

De meest gestelde vragen over tuberculose:

Wat is tuberculose?

Hoe merk ik dat ik tuberculose heb?

Is tuberculose altijd besmettelijk?

Bestaat er een vaccinatie tegen tuberculose?

Overzicht van alle vragen

Om TBC de wereld uit te krijgen is uw support onmisbaar!

Doneren:

Eénmalig of maandelijks

Nalaten met een goed gevoel

Neem KNCV Tuberculosefonds op in uw testament

Heeft u iets te vieren?

Doneer aan KNCV Tuberculosefonds via geef.nl

Steun ons gratis bij een boeking via booking.com

Booking.com/supportkncvtbc

Deel uw ervaring met tuberculose

Dwalen in verhalen

Wereldwijd sterven elke dag nog ruim 4.000 mensen aan TBC. Onnodig, want tuberculose is te genezen!

Wat wij doen

Over ons

Waar we werken wereldwijd

Voor zorgprofessionals in Nederland

Bij- en nascholing

Onderzoek

Ondersteuning van patienten

Bezoek adres

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Post adres

Postbus 146
2501 CC Den Haag

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.